These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Usefulness of vasodilators in congestive cardiac insufficiency: studies with prazosin]. Conti CR; Miles D; Mehta J Cardiology; 1980; 66 Suppl 2():186-92. PubMed ID: 7285029 [No Abstract] [Full Text] [Related]
7. Oral vasodilator therapy with prazosin in severe congestive heart failure. Awan NA; Mason DT Am Heart J; 1981 May; 101(5):695-700. PubMed ID: 7223616 [No Abstract] [Full Text] [Related]
8. [Vasodilator therapy with alpha-receptor blockaders. Acute and chronic effect of prazosin and phentolamine in congestive heart failure]. Kersting F; Samosny G; Kasper W; Schuster HP Med Welt; 1981 Jun; 32(26):1040-5. PubMed ID: 6114383 [No Abstract] [Full Text] [Related]
9. [Effect of vasodilator agents in chronic heart failure]. Bussmann WD Med Klin; 1981 Apr; 76(9):249-53. PubMed ID: 6456408 [No Abstract] [Full Text] [Related]
10. The role of vasodilator therapy in the management of the patient with acute myocardial infarction. Wagner GC; Robinson PH Prim Care; 1981 Sep; 8(3):467-81. PubMed ID: 6796986 [No Abstract] [Full Text] [Related]
12. The acute and chronic haemodynamic effects of prazosin in severe congestive cardiac failure. Harper RW; Claxton H; Middlebrook K; Anderson S; Pitt A Med J Aust; 1980 Jul; 2(SP1):36-8. PubMed ID: 7421721 [No Abstract] [Full Text] [Related]
13. Vasodilator therapy for acute myocardial infarction and chronic congestive heart failure. Chatterjee K; Parmley WW J Am Coll Cardiol; 1983 Jan; 1(1):133-53. PubMed ID: 6338075 [TBL] [Abstract][Full Text] [Related]
14. Importance of neuroendocrine regulators of vascular tone and integral adrenoreceptor interaction during oral vasodilator therapy of severe congestive heart failure with prazosin. Awan NA; Beattie JM; Evenson ME; Needham KE; Mason DT J Cardiovasc Pharmacol; 1982; 4 Suppl 1():S176-80. PubMed ID: 6175836 [TBL] [Abstract][Full Text] [Related]
15. Sustained reduction of cardiac impedance and preload in congestive heart failure with the antihypertensive vasodilator prazosin. Miller RR; Awan NA; Maxwell KS; Mason DT N Engl J Med; 1977 Aug; 297(6):303-7. PubMed ID: 889599 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic application of prazosin in chronic refractory congestive heart failure. Tolerance and "tachyphylaxis" in perspective. Awan NA; Needham KE; Evenson MK; Amsterdam EE; Mason DT Am J Med; 1981 Jul; 71(1):153-60. PubMed ID: 7246573 [TBL] [Abstract][Full Text] [Related]
17. Afterload reduction in the management of congestive heart failure following acute myocardial infarction. Miller RR; Awan NA; Mason DT Adv Cardiol; 1978; 23():173-81. PubMed ID: 345758 [No Abstract] [Full Text] [Related]
18. [Vasodilator therapy of congestive heart failure: comparison of hemodynamic effects after administration of nitroprusside i.v. and oral prazosin (author's transl)]. Mauri F; Gronda E; Bossi M; Rovelli F G Ital Cardiol; 1980; 10(4):414-23. PubMed ID: 7439582 [No Abstract] [Full Text] [Related]
19. [Chronic vasodilator treatment in heart failure. II. Prazosin therapy]. Costică II; Dumitriu M; Cinteză M; Dăescu L; Bălan C Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1984; 36(5):397-403. PubMed ID: 6151226 [No Abstract] [Full Text] [Related]